| 2021-01 |
Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study |
DIGESTIVE DISEASES AND SCIENCES
|
| 2021-01 |
Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy |
GUT AND LIVER
|
| 2021-01 |
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
Elevated testosterone increases risk of hepatocellular carcinoma in men with chronic hepatitis B and diabetes mellitus |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-12 |
A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-12 |
Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection |
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-12 |
Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion |
Journal of hepatocellular carcinoma
|
| 2020-11 |
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease |
LIVER INTERNATIONAL
|
| 2020-11 |
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals |
Cancers
|
| 2020-10 |
Serial Transient Elastography Examinations to Monitor Patients With Type 2 Diabetes: A Prospective Cohort Study |
HEPATOLOGY
|
| 2020-09 |
Thiazolidinediones reduce the risk of hepatocellular carcinoma and hepatic events in diabetic patients with chronic hepatitis B |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-09 |
Serum hepatitis B core-related antigen predicts hepatocellular carcinoma in hepatitis B e antigen-negative patients |
JOURNAL OF GASTROENTEROLOGY
|
| 2020-09 |
Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-09 |
Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus |
GUT AND LIVER
|
| 2020-09 |
Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma |
JOURNAL OF VIRAL HEPATITIS
|
| 2020-09 |
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation |
Cancers
|
| 2020-08 |
One world, one pandemic, many guidelines: management of liver diseases during COVID-19 |
GUT
|
| 2020-07 |
An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia |
LIVER INTERNATIONAL
|
| 2020-07 |
How does low-level viremia affect the prognosis of patients with chronic hepatitis B? |
Clinical and molecular hepatology
|
| 2020-06 |
How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
| 2020-05 |
Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
| 2020-04 |
Unresolved issues of immune tolerance in chronic hepatitis B |
JOURNAL OF GASTROENTEROLOGY
|
| 2020-03 |
Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
Clinical and Translational Gastroenterology
|
| 2020-02 |
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest? |
Immune Network
|
| 2020-01 |
Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study |
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
|